Abstract
The intracellular chemistry and biological processing of platinum anticancer drugs have been subjects of interest following the discovery of antitumour activity for cis-diamminedichloroplatinum(II) (cis-DDP, or cisplatin, Figure 5.1) (Rosenberg et al. 1965). Although several analogous platinum compounds have received FDA approval in the USA or are in clinical trials (see next chapter), a greater understanding of the molecular mechanism of action of platinum anticancer drugs is essential for the rational design of compounds with broader therapeutic specificity and reduced side-effects. At present, cisplatin is used in the USA for the treatment of metastatic testicular tumours, metastatic ovarian tumours, various head and neck tumours, and advanced bladder cancer. It is particularly effective against testicular cancer, which is the most common form of the disease among males in the 21- to 35-year-old age group. The orderly development of cis-DDP-based combination chemotherapy regimens has led to a present cure rate for testis cancer of approximately 95 per cent (Fox and Loehrer, 1991).
Preview
Unable to display preview. Download preview PDF.
References
Admiraal, G., Alink, M., Altona, C., Dijt, F. J., van Garderen, C. J., de Graaff, R. A. G. and Reedijk, J. (1992). Conformation of Pt(dien)[d(ApGpA)-N7(2)] in the solid state and in aqueous solution, as determined with single-crystal X-ray diffraction and high-resolution NMR spectroscopy in solution. J. Am. Chem. Soc., 114, 930–938
Akaboshi, M., Kawai, K., Maki, H., Akuta, K., Ujeno, Y. and Miyahara, T. (1992). The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration. Jap. J. Cancer Res., 83, 522–526
Anderson, K. S. (1979). Platinum(II) complexes generate frameshift mutations in test strains of Salmonella typhimurium. Mutation Res., 67, 209–214
Andrews, P. A. and Howell, S. B. (1990). Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35–43
Appleton, T. G., Hall, J. R., Neale, D. W. and Thompson, C. S. M. (1990). Reactions of the cis-diamminediaquaplatinum(II) cation with 2-aminomalonic acid and its homologues, aspartic and glutamic acids. Rearrangements of metastable complexes with carboxylate-bound ligands to N,0-chelates and formation of di- and trinuclear complexes. Inorg. Chem., 29, 3985–3990
Appleton, T. G., Hall, J. R. and Ralph, S. F. (1986). 15N and 195Pt N.M.R. study of the effect of chain length, n, on the reactions of amino acids, +NH,(CH2)„CO2 (n = 1, 2, 3), with platinum(II) ammine complexes. Aust. J. Chem., 39, 1347–1362
Arpalahti, J. (1990). Kinetics for pH-dependent complexation of aquated cisdiammineplatinum(II) with inosine and 1-methylinosine. Inorg. Chem., 29, 4598–4602
Arpalahti, J. and Lehikoinen, P. (1990). Kinetics of complexation of aquated Pt(II)(dien) with inosine and 1-methylinosine as a function of pH. Inorg. Chem., 29, 2564–2567
Arpalahti, J. and Lippert, B. (1990). Coordination of aquated cis-platinum(II) diamines to purine nucleosides. Kinetics of complex formation. Inorg. Chem., 29, 104–110
Bancroft, D. P., Lepre, C. A. and Lippard, S. J. (1990). i95Pt NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA. J. Am. Chem. Soc., 112, 6860–6871
Banerjee, S. K., Borden, A., Christensen, R. B., LeClerc, J. E. and Lawrence, C. W. (1990). SOS-dependent replication past a single trans-syn T-T cyclobutane dimer gives a different mutation spectrum and increased error rate compared with replication past this lesion in uninduced cells. J. Bacteriol., 172, 2105–2112
Banjar, Z. M., Hnilica, L. S., Briggs, R. C., Stein, J. and Stein, G. (1984). cis- and trans-Diamminedichloroplatinum(II)-mediated crosslinking of chromosomal non-histone proteins to DNA in HeLa cells. Biochemistry, 23, 1921–1926
Basu, A., Teicher, B. A. and Lazo, J. S. (1990). Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J. Biol. Chem., 265, 8451–8457
Basu, A. K. and Essigmann, J. M. (1988). Site-specifically modified oligodeoxynucleotides as probes for the structural and biological effects of DNA-damaging agents. Chem. Res. Toxicol, 1, 1–18
Baudin, F., Romby, P., Romaniuk, P. J., Ehresmann, B. and Ehresmann, C. (1989). Crosslinking of transcription factor TFIIIA to ribosomal 5S RNA from X. laevis by trans-diamminedichloroplatinum(II). Nucleic Acids Res., 17, 10035–10046
Bellon, S. F., Coleman, J H and Lippard, S. J. (1991). DNA unwinding produced by site-specific intrastrand crosslinks of the antitumor drug cis-diamminedichloro-platinum(II). Biochemistry, 30, 8026–8035
Berners-Price, S. J. and Kuchel, P. W. (1990a). Reaction of cis- and trans- [PtC12(NH3)2] with reduced glutathione inside human red blood cells, studied by H and 15N-{1H) DEPT NMR. J. Inorg. Biochem., 38, 327–345
Berners-Price, S. J. and Kuchel, P. W. (1990b). Reaction of cis- and trans[PtC12(NH3)2] with reduced glutathione studied by 1H, 13C, 195Pt and 15N-{1H} DEPT NMR. J. Inorg. Biochem., 38, 305–326
Bodenner, D. L., Dedon, P. C., Keng, P. C., Katz, J. C. and Borch, R. F. (1986). Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate rescue. Cancer Res., 46, 2751–2756
Bohr, V. A. (1991). Gene specific DNA repair. Carcinogenesis, 12, 1983–1992
Bohr, V. A., Nairn, R. S., Wassermann, K., Jones, J. C., Zhen, W. and May, A. (1991). Studies of preferential DNA repair and strand specificity of DNA repair in the DHFR gene after treatment of hamster cells with UV and chemotherapeutics. Proc. Am. Assoc. Cancer Res., 32, 4
Bowler, B. E. and Lippard, S. J. (1986). Modulation of platinum antitumor drug binding to DNA by linked and free intercalators. Biochemistry, 25, 3031–3038
Bradley, L. J. N., Yarema, K. J., Lippard, S. J. and Essigmann, J. M. (1993). Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry, 32, 982–988
Bridges, B. A. and Woodgate, R. (1985). Mutagenic repair in Eschericia coli. RecA and umuC,D gene products act at different steps in UV mutagenesis. Proc. Natl Acad. Sci. USA, 82, 4193–4197
Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E. and Lippard, S. J. (1992). Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl Acad. Sci., USA, 89, 2307–2311
Bruhn, S. L., Toney, J. H. and Lippard, S. J. (1990). Biological processing of DNA modified by platinum compounds. Prog. Inorg. Chem., 38, 477–516
Bubley, G. J., Ashbumer, B. P. and Teicher, B. A. (1991). Spectrum of cisdiamminedichloroplatinum(II) induced mutations in a shuttle vector propagated in human cells. Mol. Carcinogen., 4, 397–406
Buchanan, R. M. and Gralla, J. D. (1990). Cisplatin resistance and mechanism in a viral test system: SV40 isolates that resist inhibition by the antitumor drug have lost regulatory DNA. Biochemistry, 29, 3436–3442
Burnout, D., Daune, M. and Fuchs, R. P. P. (1987). Spectrum of cisplatin-induced mutations in Escherichia coli. Proc. Natl Acad. Sci. USA, 84, 3758–3762
Burnout, D., Gauthier, C., Chottard, J. C. and Fuchs, R. P. P. (1990). Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli. Proc. Natl Acad. Sci. USA, 87, 6087–6091
Calabresi, P. and Parks, J. R. E. (1985). In Gilman, A. G., Goodman, L. S., Rall, T. W. Murad, F. (Eds.), Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 7th edn. Macmillan, New York, pp. 1290–1291
Canon, J.-L., Humblet, Y. and Symann, M. (1990). Resistance to cisplatin: How to deal with the problem? Eur. J. Cancer, 26, 1–3
Caradonna, J. P., Lippard, S. J., Gait, M. J. and Singh, M. (1982). The antitumor drug cis-[Pt(NH3)2C12] forms an intrastrand d(GpG) crosslink upon reaction with [d(ApGpGpCpCpT)]2. J. Am. Chem. Soc., 104, 5793–5795
Cariello, N. F., Swenberg, J. A. and Skopek, T. R. (1992). In vitro mutational specificity of cisplatin in the human hypoxanthine guanine phosphoribosyltransferase gene. Cancer Res., 52, 2866–2873
Chao, C.-K., Huang, S.-L., Lee, L.-Y and Lin-Chao, S. (1991). Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis- diamminedichloroplatinum(II). Biochem. J., 277, 875–878
Chu, G. and Chang, E. (1988). Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science, 242, 564–567
Chu, G. and Chang, E. (1990). Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc. Natl Acad. Sci. USA, 87, 3324–3327
Churchill, M. E. A. and Travers, A. A. (1991). Protein motifs that recognize structural features of DNA. Trends Biochem. Sci., 16, 92–97
Ciccarelli, R. B., Solomon, M. J., Varshaysky, A. and Lippard, S. J. (1985). In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication. Biochemistry, 24, 7533–7540
Claereboudt, J., De Spiegeleer, B., Bruijn, E. A. D., Gijbels, R. and Claeys, M. (1989a). Structural characterization of cisplatin analogues by fast atom bombardment (FAB) and laser microprobe mass spectrometry (LAMMA). J. Pharm. Biomed. Anal., 7, 1599–1610
Claereboudt, J., Spiegeleer, B. D., Lippert, B., Bruijn, E. A. D. and Claeys, M. (1989b). Fast atom bombardment and tandem mass spectrometry for the structural characterization of cisplatin analogs and bis-nucleobase adducts with cisplatin. Spectrosc. Int. J., 7, 91–112
Comess, K. M., Burstyn, J. N., Essigmann, J. M. and Lippard, S. J. (1992). Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry, 31, 3975–3990
Comess, K. M., Costello, C. E. and Lippard, S. J. (1990). Identification and characterization of a novel linkage isomerization in the reaction of transdiamminedichloroplatinum(II) with d(TCTACGCGTTCT). Biochemistry, 29, 2102–2110
Comess, K. M. and Lippard, S. J. (1990). Commentary on: Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). Chemtracts: Biochemistry and Molecular Biology, 1, 336–337
Corda, Y., Anin, M.-F., Leng, M. and Job, D. (1992). RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cisdiamminedichloroplatinum(II). Biochemistry, 31, 1904–1908
Corda, Y., Job, C., Anin, M.-F., Leng, M. and Job, D. (1991). Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry, 30, 222–230
Costello, C.E., Comess, K. M., Plaziak, A. S., Bancroft, D. P. and Lippard, S. J. (1992). Fast atom bombardment and high performance tandem mass spectrometry of platinum(II) oligodeoxyribonucleotide fragments. Int. J. Mass Spectrom. Ion Processes, 122, 255–279
Dabholkar, M., Parker, R. and Reed, E. (1992). Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T-cell lines. Mutation Res., 274, 45–56
deBoer, J. G. and Glickman, B. W. (1989). Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene. Carcinogenesis, 10, 1363–1367
Dedon, P. C. and Borch, R. F. (1987). Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Biochem. Pharmacol., 36, 1955–1964
DePamphilis, M. L. (1988). Transcriptional elements as components of eukaryotic origins of DNA replication. Cell, 52, 635–638
Dieter, I., Lippert, B. Schöllhom, H. and Thewalt, U. (1990). Coordination chemistry of trans-(NH3)2Pt(II) with uracil nucleobases. A comparison with cis-(NH3)2Pt(II). Z. Naturforsch., 45b, 731–740
Donahue, B. A., Augot, M., Bellon, S. F., Treiber, D. K., Toney, J. H., Lippard, S. J. and Essigmann, J. M. (1990). Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry, 29, 5872–5880
Dynan, W. S. and Tjian, R. (1985). Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature, 316, 774–778
Eastman, A. (1986). Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry, 25, 3912–3915
Enns, R. E. and Howell, S. B. (1992). Isolation of a gene associated with resistance to cisplatin. In Howell, S. B. (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Plenum Press, New York, pp. 213–220
Fichtinger-Schepman, A. M. J., Baan, R. A. and Berends, F. (1989a). Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels. Carcinogenesis, 10, 2367–2369
Fichtinger-Schepman, A. M. J., Baan, R. A., Luiten-Schuite, A., van Dijk, M. and Lohman, P. H. M. (1985a). Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum(II) and analysis of adduct-related DNA unwinding. Chem. -biol. Interact., 55, 275–288
Fichtinger-Schepman, A. M. J., Dijt, F. J., Bedford, P., van Oosterom, A. T., Hill, B. T. and Berends, F. (1988). Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques. In Methods for Detecting DNA Damaging Agents in Humans. International Agency for Research on Cancer, pp. 321–328
Fichtinger-Schepman, A. M. J., Lohman, P. H. M. and Reedijk, J. (1982). Detection and quantitation of adducts formed upon reaction of diamminedichloroplatinum(II) with DNA, by anion-exchange chromatography after enzymatic degradation. Nucleic Acids Res., 10, 5345–5356
Fichtinger-Schepman, A., van Oosterom, A. T., Lohman, P. H. M. and Berends, F. (1987). cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cisdiamminedichloroplatinum(II). Cancer Res., 47, 3000–3004
Fichtinger-Schepman, A. M. J., van der Veer, J. L., den Hartog, J. H. J., Lohamn, P. H. M. and Reedijk, J. (1985b). Adducts of the antitumor drug cisdiamminedichloroplatinum(II) with DNA: Formation, identification, and quantitation. Biochemisty, 24, 707–713
Fichtinger-Schepman, A. M. J., van der Velde-Visser, S. D., van DijkKnijnenburg, H. C. M., van Oosterom, A. T., Baan, R. A. and Berends, F. (1990). Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: Comparison with in vitro adduct formation. Cancer Res., 50, 7887–7894
Fichtinger-Schepman, A. M. J., Vendrik, C. P. J., van Dijk-Knijneburg, W. C. M., de Jong, W. H., van der Minnen, A. C. E., Claessen, A. M. E., van der Velde-Visser, S. D., de Groot, G., Wubs, K. L., Steerenberg, P. A., Schor-nagel, J. H. and Berends, F. (1989b). Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma. Cancer Res., 49, 2862–2867
Filipski, J., Kohn, K. W. and Bonner, W. M. (1983). Differential crosslinking of histones and non-histones in nuclei by cisPt(II). FEBS Lett., 152, 105–108
Fok, E. M. (1990). Computation of kinetics of cis-dichlorodiaminoplatinum(II) hydrolysis. Koordinatsionnaya Khimiya, 16, 1554–1559
Forsti, A., Leppala, S., Takala, M., Laatikainen, R. and Hemminki, K. (1989). Kinetics of reaction of cis-diamminedichloroplatinum(II) with DNA. Pharmacol. Toxicol., 64, 120–125
Fox, E. P. and Loehrer, P. J. (1991). Chemotherapy for advanced testicular cancer. Hematology/Oncology Clinics of North America, 5, 1173–1187
Frommer, G. and Lippert, B. (1990). Head-tail oriented nucleobases (B = guanine, cytosine) in cis-A2PtB2 resisting cyanide substitution. Implications for the nature of strongly DNA-bound cisplatin. Inorg. Chem., 29, 3259–3260
Ganeva, R. L., Spassovska, N. C. and Genchev, D. D. (1990). The effect of some platinum compounds on the biosynthesis of RNA and its precursors. J. Inorg. Biochem., 40, 13–18
Gibbons, G. R., Kaufmann, W. K. and Chaney, S. G. (1991). Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Carcinogenesis, 12, 2253–2257
Godwin, A. K., Meister, A., Odwyer, P. J., Huang, C. S., Hamilton, T. C. and Anderson, M. E. (1992). High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl Acad. Sci. USA, 89, 3070–3074
Gralla, J. D., Sasse-Dwight, S. and Poljak, L. G. (1987). Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs. Cancer Res., 47, 5092–5096
Green, M. and Miller, J. M. (1987). A cyclic nucleobase phosphate: Fast atom bombardment studies on a 1: 1 mixture of cis-[Pt(NH3)2(OH)21(CF3SO3)2 and guanosine 5’-monophosphoric acid. J. Chem. Soc., Chem. Commun., 1864–1865
Greene, M. H. (1992). Is cisplatin a human carcinogen. J. Nat! Cancer Inst., 84, 306–312
Haneda, H., Katabami, M., Miyamoto, H., Isobe, H., Shimizu, T., Ishiguro, A., Moriuti, T., Takasaki, Y. and Kawakami, Y. (1991). The relationship of the proliferating cell nuclear antigen protein to cis-DDP resistance of a murine leukemia cell line P388/CDDP. Oncology, 48, 234–238
Hansson, J. and Wood, R. D. (1989). Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(H). Nucleic Acids Res., 17, 8073–8091
Harder, H. C. and Rosenberg, B. (1970). Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int. J. Cancer, 6, 207–216
Harrison, S. C. (1991). A structural taxonomy of DNA-binding domains. Nature, 353, 715–719
Heiger-Bemays, W. J., Essigmann, J. M. and Lippard, S. J. (1990). Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication. Biochemistry, 29, 8461–8466
Hemminiki, K. and Thilly, W. G. (1988). Binding of cisplatin to specific sequences of human DNA in vitro. Mutation Res., 202, 133–138
Hoffmann, J.-S., Hubscher, U., Michot, B. and Villani, G. (1991). Interaction of cis-diamminedichloroplatinum(II) with single-stranded DNA in the presence or absence of Escherichia coli single-stranded binding protein. Biochem. Pharma-col., 42, 1393–1398
Hoffmann, J.-S., Johnson, N. P. and Villani, G. (1989). Conversion of monofunctional DNA adducts of cis-diamminedichloroplatinum(II) to bifunctional lesions. J. Biol. Chem., 264, 15130–15135
Hollander, M. C. and Fornace, A. J., Jr. (1989). Induction of fos RNA by DNA-damaging agents. Cancer Res., 49, 1687–1692
Howe-Grant, M. and Lippard, S. J. (1980). Aqueous platinum(II) chemistry; Binding to biological molecules. Metal Ions Biol. Syst., 11, 63–125
Howell, S. B., Pfeifle, C. E., Wing, W. E. and Olshen, R. A. (1983). Intraperitoneal cis-diamminedichloroplatinum(II) with systemic thiosulfate protection. Cancer Res., 43, 1426–1431
Howle, J. A. and Gale, G. R. (1970). cis-DDP: Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochem. Pharmacol. 19 2757–2762
Iakovidis, A., Hadjiliadis, N., Dahan, F., Laussac, J.-P. and Lippert, B. (1990). Complete displacement of N,O bound amino acids (amacH) in cis-[(NH3)2Pt(amac)]NO3 chelates by 9-methylguanine (9-MeGH) and 9-methyladenine (9-MeA). The crystal structure of cis-[(NH3)2Pt(9-MeA-N7)2](NO3)2.1.5 H2O. Inorg. Chim. Acta, 175, 57–63
Inagaki, K., Alink, M., Nagai, A., Kidani, Y. and Reedijk, J. (1990). Unusual isomerization reaction of a platinum-dinucleotide compound. Inorg. Chem., 29, 2183–2185
Inagaki, K., Tomita, A. and Kidani, Y. (1988). Studies on the reaction products of antitumor platinum complexes with d(ApG), d(GpA) and d(pGpA). 2’-Deoxy sugar is favorable for G-N7, A-N1 chelation. Bull. Chem. Soc. Jpn, 61, 2825–2831
Isonishi, S., Andrews, P. and Howell, S. (1990). Increased sensitivity to cisdiamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-Tetradecanoylphorbol 13-acetate. J. Biol. Chem., 265, 3623–3627
Isonishi, S., Hom, D. K., Thiebaut, F. B., Mann, S. C., Andrews, P. A., Basu, A., Lazo, J. S., Eastman, A. and Howell, S. B. (1991). Expression of the c-Ha-ras oncogene in mouse NIH-3T3 cells induces resistance to cisplatin. Cancer Res., 51, 5903–5909
Jäckel, M. and Köpf-Maier, P. (1991). Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas. Cancer Chemother. Pharmacol., 27, 464–471
Johnson, N. P., Hoeschele, J. D., Rahn, R. O., O’Neill, J. P. and Hsie, A. W. (1980). Mutagenicity, cytotoxicity, and DNA binding of platinum(II) chloro-amines in Chinese hamster ovary cells. Cancer Res., 40, 1463–1468
Johnson, N. P., Macquet, J. P., Wiebers, J. L. and Monsarrat, B. (1982). Structures of the adducts formed between [Pt(dien)Cl]Cl and DNA in vitro. Nucleic Acids Res., 10, 5255–5271
Johnson, N. P., Mazard, A. M., Escalier, J. and Macquet, J. P. (1985). Mechanism of the reaction between cis-[PtC12(NH3)2] and DNA in vitro. J. Am. Chem. Soc., 107, 6376–6380
Jones, J. C., Zhen, W., Reed, E., Parker, R. J., Sancar, A. and Bohr, V. A. (1991). Gene-specific formation and repair of cisplatin intrastrand adducts and intrastrand cross-links in Chinese hamster ovary cells. J. Biol. Chem., 266, 7101–7107
Jones, M. M. and Beaty, J. A. (1991). Rate of displacement of guanosine by cyanide from cis-diamminebis(guanosine)platinum(II) chloride determined by using 13C NMR. Inorg. Chem., 30, 1584–1587
Kashani-Sabet, M., Wang, W. and Scanlon, K. J. (1990). Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells. J. Biol. Chem., 265, 11285–11288
Kasselouri, S., Laussac, J.-P. and Hadjiliadis, N. (1989). trans-Ternary complexes of Pd(II) with nucleosides and dipeptides. Models for trans-DDP-DNA-protein crosslinks. Inorg. Chim. Acta, 166, 239–248
Kawai, K., Kamatani, N., Georges, E. and Ling, V. (1990). Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum(II). J. Biol. Chem., 265, 13137–13142
Keck, M. V. and Lippard, S. J. (1992). Unwinding of supercoiled DNA by platinum-ethidium and related complexes. J. Am. Chem. Soc., 114, 3386–3390
Kelland, L. R., Mistry, P., Abel, G., Freidlos, F., Loh, S. Y., Roberts, J. J. and Harrap, K. R. (1992). Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminatous germ cell line. Cancer Res., 52, 1710–1716
Kelley, S. and Rozencweig, M. (1989). Resistance to platinum compounds: Mechanisms and beyond. Eur. J. Cancer Clin. Oncol., 25, 1135–1140
Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H. and Lazo, J. S. (1988). Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241, 1813–1815
Kline, T. P., Marzilli, L. G., Live, D. and Zon, G. (1989). Investigations of platinum amine induced distortions in single- and double-stranded oligodeoxyribonucleotides. J. Am. Chem. Soc., 111, 7057–7068
Krizanovic, O., Pesch, F. J. and Lippert, B. (1989). Nucleobase displacement from trans-diamine-platinum(II) complexes. A rationale for the inactivity of transDDP as an antitumor agent? Inorg. Chim. Acta, 165, 145–146
Langford, C. H. and Gray, H. B. (1965). Ligand Substitution Processes. W. A. Benjamin, New York
Lemaire, M.-A., Schwartz, A., Rahmouni, A. R. and Leng, M. (1991). Interstrand crosslinks are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum(II) and DNA. Proc. Natl Acad. Sci. USA, 88, 1982–1985
Lempers, E. L. M. and Reedijk, J. (1990a). Characterization of products from [PtCI(dien)]CI and S-adenosyl-L-homocysteine. Evidence for a pH-dependent migration of the platinum moiety from the sulfur atom to the amine group and vice versa. Inorg. Chem., 29, 1880–1884
Lempers, E. L. M. and Reedijk, J. (1990b). Reversibility of binding of cisplatin-methionine in proteins by diethyldithiocarbamate or thiourea: A study with model adducts. Inorg. Chem., 29, 217–222
Leopold, W. R., Miller, E. C. and Miller, J. A. (1979). Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat. Cancer Res., 39, 913–918
Lepre, C. A., Chassot, L., Costello, C. E. and Lippard, S. J. (1990). Synthesis and characterization of trans-[Pt(NH3)2C12] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG). Biochemistry, 29, 811–823
Lim, M. C. and Martin, R. B. (1976). Nature of cis-amine Pd(II) and antitumor cis-amine Pt(II) complexes in aqueous solutions. J. Inorg. Nucl. Chem., 38, 1911–1914
Lippard, S. J. and Hoeschele, J. D. (1979). Binding of cis- and transdichlorodiammineplatinum(II) to the nucleosome core. Proc. Natl Acad. Sci. USA, 76, 6091–6095
Lippert, B. (1989). Platinum nucleobase chemistry. Prog. Inorg. Chem., 37, 1–97
Litterst, C. L. (1984). In Hacker, M. P., Douple, E. B. and Krakoff, I. H. (Eds), Platinum Coordination Complexes in Cancer Chemotherapy. Martinus Nijhoff, Dordrecht, p. 78
Litterst, C. L., Gram, T. E., Dedrich, R. L., Leroy, A. F. and Guarino, A. M. (1976). Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) to dogs. Cancer Res., 36, 2340–2344
Litterst, C. L., LeRoy, A. F. and Guarino, A. M. (1979). Disposition and distribution of platinum following parenteral administration of cis-dichlorodi-ammineplatinum(II) to animals. Cancer Treat. Rep., 63, 1485–1492
Loehrer, P. J. and Einhorn, L. H. (1984). Cisplatin. Ann. Intern. Med., 100, 704–713
McCloskey, J. A. (1982). In Alderweireldt, F. C. and Esmans, E. L. (Eds), Nucleosides, Nucleotides, and Their Biological Applications. University of Antwerp, Belgium, pp. 47–67
May, A., Nairn, R. S., Okumoto, D. S., Wassermann, K., Stevnsner, T., Jones, J. C. and Bohr, V. A. (1993). Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin. J. Biol. Chem., 268, 1650–1657
Malinge, J.-M., Schwartz, A. and Leng, M. (1987). Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum(II), ethidium bromide and nucleic acids. Nucleic Acids Res., 15, 1779–1797
Marrot, L. and Leng, M. (1989). Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II). Biochemistry, 28, 1454–1461
Martin, L. B., III, Schreiner, A. F. and van Breemen, R. B. (1991). Characterization of cisplatin adducts of oligonucleotides by fast atom bombardment mass spectrometry. Anal. Biochem., 193, 6–15
Masuda, H., Tanaka, T., Matsuda, H. and Kusaba, I. (1990). Increased removal of DNA-Marilyn platinum in a human ovarian cancer cell line resistant to cisdiamminedichloroplatinum(II). Cancer Res., 50, 1863–1866
Mellon, I. M. and Hanawalt, P. C. (1989). Induction of the Eschericia coli lactose operon selectively increases repair of its transcribed DNA strand. Nature, 342, 95–98
Mellon, I. M., Spivak, G. S. and Hanawalt, P. C. (1987). Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell, 51, 241–249
Millar, D. P., Ho, K. M. and Aroney, M. J. (1988). Modification of DNA dynamics by platinum drug binding: A time-dependent fluorescence depolarization study of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA. Biochemistry, 27, 8599–8606
Miller, C. A., III, Cohen, M. D. and Costa, M. (1991). Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis, 12, 269–276
Miller, S. E. and House, D. A. (1989a). The hydrolysis products of cisdiamminedichloroplatinum(II). 1. The kinetics of formation and anation of the cis-diammine(aqua)chloroplatinum(II) cation in acidic aqueous solution. Inorg. Chim. Acta, 161, 131–137
Miller, S. E. and House, D. A. (1989b). The hydrolysis products of cisdichlorodiammineplatinum(II). 2. The kinetics of formation and anation of the cis-diamminedi(aqua)platinum(II) cation. Inorg. Chim. Acta, 166, 189–197
Miller, S. E. and House, D. A. (1990). The hydrolysis products of cisdichlorodiammineplatinum(II). 3. Hydrolysis kinetics at physiological pH. Inorg. Chim. Acta, 173, 53–60
Mis, J. R. A. and Kunz, B. A. (1990). Analysis of mutations induced in the SUP4-o gene of Saccharomyces cerevisiae by cis-diammine dichloroplatinum(II). Carcinogenesis, 11, 633–638
Miyazaki, M., Kohno, K., Saburi, Y., Matsuo, K., Ono, M., Kuwano, M., Tsuchida, S., Sato, K., Sakai, M. and Muramatsu, M. (1990). Drug resistance to cis-diamminedichloroplatinum(II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase PI gene. Biochem. Biophys. Res. Commun., 166, 1358–1364
Mukundan, S., Jr., Xu, Y., Zon, G. and Marzilli, L. G. (1991). Heteronuclear 13C–1H NMR investigation of the effects on an oligodeoxyribonucleotide of intrastrand crosslinking by a Pt anticancer drug. A large shift of C3’ accompanies an S to N conformation change. J. Am. Chem. Soc., 113, 3021–3027
Naser, L. J., Pinto, A. L., Lippard, S. J. and Essigmann, J. M. (1988). Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2{d(GpG)}], built into a specific site in a viral genome. Biochemistry, 27, 4357–4367.
Ogawa, M., Gale, G. R. and Keim, S. S. (1975). Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells. Cancer Res., 35, 1398–1401
Page, J. D., Husain, I., Sancar, A. and Chaney, S. G. (1990). Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality. Biochemistry, 29, 1016–1024
Parker, R. J., Gill, I., Tarone, R., Vionnet, J. A., Grunberg, S., Muggia, F. M. and Reed, E. (1991). Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis, 12, 1253–1258
Patel D. J. (1992). Covalent carcinogenic guanine-modified DNA lesions: Solution structures of adducts and crosslinks. Current Opinion Struct. Biol., 2, 345–353
Patton, T. F., Himmelstein, K. J., Belt, R., Bannister, S. J., Sternson, L. A. and Repta, A. J. (1978). Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in Man. Cancer Treat. Rep., 62, 1359–1362
Peerey, L. M. and Kostic, N. M. (1987). Transition-metal compounds as new reagents for selective cross-linking of proteins. Synthesis and characterization of 2 bis(cytochrome c) complexes of platinum. Inorg. Chem., 26, 2079–2083
Pesch, F. J., Preut, H. and Lippert, B. (1990). Mixed nucleobase, amino acid complexes of Pt(II). Preparation and X-ray structure of trans-[(CH3NH2)2Pt(1MeC-N 3)(gly-N)]NO3.2H2O and its precursor trans-[(CH3NH2)2Pt(1-MeC-N 3)Cl]Cl•H2O. Inorg. Chim. Acta, 169, 195–200
Pil, P. M. and Lippard, S. J. (1992). Specific binding of chromosomal protein HMG 1 to DNA damaged by the anticancer drug cisplatin. Science, 256, 234–237
Pinto, A. L. and Lippard, S. J. (1985a). Binding of the antitumor drug cisdiamminedichloroplatinum(II) (cisplatin) to DNA. Biochem. Biophys. Acta, 780, 167–180
Pinto, A. L. and Lippard, S. J. (1985b). Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum(II). Proc. Natl Acad. Sci. USA, 82, 4616–4619
Pinto, A. L., Naser, L. J., Essigmann, J. M. and Lippard, S. J. (1986). Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugs. J. Am. Chem. Soc., 108, 7405
Pizzo, S. V., Roche, P. A., Feldman, S. R. and Gonias, S. L. (1986). Further characterization of the platinum-reactive component of the a2-macroglobulinreceptor recognition site. Biochem. J., 238, 217–225
Pizzo, S. V., Swaim, M. W., Roche, P. A. and Gonias, S. L. (1988). Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. J. Inorg. Biochem., 33, 67–76
Plaziak, A. S., Costello, C. E., Comess, K. M., Bancroft, D. P. and Lippard, S. J. (1990). High performance tandem mass spectrometry of platinated oligonucleotide fragments. In Proceedings of the 38th ASMS Conference on Mass Spectrometry and Allied Topics, Tucson, Arizona, pp. 792–793
Plooy, A. C. M., van Dijk, M. and Lohman, P. H. M. (1984). Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Cancer Res., 44, 2043–2051
Poirier, M. C., Egorin, M. J., Fichtinger-Schepman, A. M. J., Yuspa, S. H. and Reed, E. (1988). DNA adducts of cisplatin and carboplatin in tissues of cancer patients. In Bartsch, H., Hemminki, K. and O’Neil, I. K. (Eds), Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. IARC Scientific Publications, Lyon, pp. 313–320
Poirier, M. C., Reed, E., Litterst, C. L., Katz, D. and Guptaburt, S. (1992). Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res., 52, 149–153
Popoff, S. C., Beck, D. J. and Rupp, W. D. (1987). Repair of plasmid DNA damaged in vitro with cis- or trans-diamminedichloroplatinum(II) in Escherichia coli. Mutation Res., 183, 129–137
Ptak, M., Rahmouni, A., Mazeau, K., Thuong, N. T. and Leng, M. (1989). Structure of the intrastrand cis-[Pt(NH3)2{d(GpCpG)}] adduct in a dodecanucleotide duplex I. A 1H and 31P n.m.r. study. Anti-cancer Drug Design, 4, 53–61
Ratilla, E. M. A., Scott, B. K., Moxness, M. S. and Kostic, N. M. (1990). Terminal and new bridging coordination of methylguanidine, arginine, and canavanine to platinum(II). The first crystallographic study of bonding between a transition metal and a guanidine ligand. Inorg. Chem., 29, 918–926
Roberts, J. J. and Friedlos, F. (1987). Differential toxicity of cis- and transdiamminedichloroplatinum(II) toward mammalian cells: Lack of any difference in the rates of loss of their DNA-bound adducts. Cancer Res., 47, 31–36
Robichaud, A., Mehra, M.-C., Jankowski, C., Virelizier, H., Butour, J.-L. and Johnson, N. P. (1989). Study of platination of nucleic acids using atomic absorption and mass spectrometry. Spectroscopy Lett., 22, 59–68
Roos, I. A. G., Thomson, A. J. and Eagles, J. (1974). Mass spectrometric studies of the interaction of platinum complexes with nucleoside analogues. Chem.-biol. Interact., 8, 421–427
Rosenberg, B., Van Camp, L. and Krigas, T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature, 205 698
Royer-Pokora, B., Gordon, L. K. and Haseltine, W. A. (1981). Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis- and trans-dichlorodiammineplatinum(II) examples. Nucleic Acids Res., 9, 4595–4609
Sancar, A. and Sancar, G. B. (1988). DNA repair enzymes. Ann. Rev. Biochem., 57, 29–67
Santos, R. A., Tang, P. and Harbison, G. S. (1989). Determination of the DNA sugar pucker using 13C NMR spectroscopy. Biochemistry, 28, 9372–9378
Schilder, R., Hall, L., Monks, A., Handel, L., Fornace, A., Jr., Ozols, R., Fojo, A. and Hamilton, T. C. (1990). Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int. J. Cancer, 45, 416–422
Schwarts, A., Marrot, L. and Leng, M. (1989). Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry, 28, 7975–7979
Schwartz, A., Marrot, L. and Leng, M. (1989). Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry, 28, 7975–7979
Selby, C. P. and Sancar, A. (1990). Transcription preferentially inhibits nucleotide excision repair of the template DNA strand in vitro. J. Biol. Chem., 265, 21330–21336
Selby, C. P. and Sancar, A. (1991). Gene- and strand-specific repair in vitro: Partial purification of a transcription-repair coupling factor. Proc. Natl Acad. Sci. USA, 88, 8232–8236
Shellard, S. A., Hosking, L. K. and Hill, B. T. (1991). Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Cancer Res., 51, 4557–4564
Sherman, S. E. and Lippard, S. J. (1987). Structural aspects of platinum anticancer drug interactions with DNA. Chem. Rev., 87, 1153–1181
Sip, M., Schwartz, A., Voyelle, F., Ptak, M. and Leng, M. (1992). Distortions induced in DNA by cis-platinum interstrand adducts. Biochemistry, 31, 2508–2513
Struik, A. F., Zuiderwijk, C. T. M., Vanboom, J. H., Elding, L. I. and Reedijk, J. (1991). Guanine-06 methylation reduces the reactivity of d(GpG) toward platinum complexes. J. Inorg. Biochem., 44, 249–260
Szymkowski, D. E., Yarema, K., Essigmann, J. M., Lippard, S. J. and Wood, R. D. (1993). An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc. Natl Acad. Sci. USA, 89, 10772–10776
Taylor, J. and O’Day, C. L. (1990). cis-syn Thymine dimers are not absolute blocks to replication by DNA polymerase I of Escherichia coli in vitro. Biochemistry 29,1624–1632
Teicher, B. A., Herman, T. S., Holden, S. A., Wang, Y., Pfeffer, M. R., Crawford, J. W. and Frei, E., III (1990). Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science, 247, 1457–1462
Terheggen, P. M. A. B., Emondt, J. Y., Root, B. G. J., Schrier, P. I., Den Engelse, L. and Begg, A. C. (1990). Correlation between cell killing by cisdiamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Res., 50, 3556–3561
Terheggen, P. M. A. B., Root, B. G. J., Lempers, E. L. M., van Tellingen, O., Begg, A. C. and den Engelse, L. (1991). Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides. Cancer Chemother. Pharmacol., 28, 185–191
Terleth, C., van de Putte, P. and Brouwer, J. (1991). New Insights in DNA Repair: Preferential Repair of Transcriptionally Active DNA. Mutagenesis, 6, 103–111
Tilby, M. J., Johnson, C., Knox, R. J., Cordell, J., Roberts, J. J. and Dean, C. J. (1991). Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res., 51, 123–129
Toney, J. H., Donahue, B. A., Kellett, P. J., Bruhn, S. L., Essigmann, J. M. and Lippard, S. J. (1989). Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II). Proc. Natl Acad. Sci. USA, 86, 8328–8332
Tullius, T. D. and Lippard, S. J. (1981). cis-Diamminedichloroplatinum(II) binds in a unique manner to oligo(dG)-Oligo(dC) sequences in DNA — A new assay using exonuclease III. J. Am. Chem. Soc., 103, 4620–4622
Tullius, T. D. and Lippard, S. J. (1982). Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II). Proc. Natl Acad. Sci. USA, 79, 3489–3492
Urata, H. and Akagi, M. (1989). Mechanism of the reversal reaction of platinated DNA with thiourea studied by platinated 5’-GMP. Biochem. Biophys. Res. Commun., 161, 819–824
Urata, H., Fujikawa, K., Tamura, M. and Akagi, M. (1990). Stability of platinated oligonucleotide duplexes containing a base pair mismatch at the site complementary to the platination site. J. Am. Chem. Soc., 112, 8611–8612
Urata, H., Ueno, M., Yamasaki, F. and Akagi, M. (1991). Interstrand crosslinking of the hexadeoxynucleotide d(TACGTA) upon reaction with transdiamminedichloroplatinum(II). Biochem. Biophys. Res. Commun., 175, 537–542
van Garderen, C. J., Altona, C. and Reedijk, J. (1988). Alterations in the d(CpGpT) structure in solution as a result of [platinum chloro(diethylenetriamine]+ binding. Eur. J. Biochem., 178, 115–121
van Garderen, C. J., Altona, C. and Reedijk, J. (1990). Conformational changes in a single- and double-stranded nonanucleotide upon complexation of a monofunctional platinum compound as studied by 111 NMR, 31P NMR, and CD methods. Inorg. Chem., 29, 1481–1487
van Garderen, C. J., Bloemink, M. J., Richardson, E. and Reedijk, J. (1991). Formation and structure of the reaction products of PtC12(en) with d(pGpG) and d(GpG); preference for d(GpG) chelation after phosphate dehydronation. J. Inorg. Biochem., 42, 199–205
van Garderen, C. J., van den Elst, H., van Boom, J. H., Reedijk, J. and van Houte, L. P. A. (1989). A double-stranded DNA fragment shows a significant decrease in double-helix stability after binding of monofunctional platinum amine compounds. J. Am. Chem. Soc., 111, 4123–4125
Villani, G., Hübscher, U. and Butour, J. L. (1988). Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: A comparison between E. coli DNA polymerase I and eucaryotic DNA polymerase a. Nucleic Acid Res., 16, 4407–4418
Visse, R., de Ruijter, M. Brouwer, J., Brandsma, J. A. and van de Putte, P. (1991). uvr Excision repair protein complex of Eschericia coli binds to the convex side of a cisplatin-induced kink in the DNA. J. Biol. Chem., 266, 7609–7617
Vrieling, H., van Rooijen, M. L., Groen, N. A., Zdzienicka, Z., Simons, J. W. I. M., Lohman, P. H. M., and van Zeeland, A. A. (1989). DNA Strand Specificity for UV-induced Mutations in Mammalian Cells. Mol. Cell. Biol., 9, 1277–1283
Walker, G. C. (1984). Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol. Rev., 48, 60–93
Editor information
Editors and Affiliations
Copyright information
© 1993 The contributors
About this chapter
Cite this chapter
Comess, K.M., Lippard, S.J. (1993). Molecular Aspects of Platinum-DNA Interactions. In: Neidle, S., Waring, M.J. (eds) Molecular Aspects of Anticancer Drug-DNA Interactions. Topics in Molecular and Structural Biology. Palgrave, London. https://doi.org/10.1007/978-1-349-12356-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-349-12356-8_5
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-12358-2
Online ISBN: 978-1-349-12356-8
eBook Packages: EngineeringEngineering (R0)